Reviva Pharmaceuticals Holdings, Inc. Common Stock
RVPHReviva Pharmaceuticals Holdings, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. Founded to leverage its expertise in drug discovery and development, Reviva aims to address unmet medical needs through innovative solutions. The company's pipeline includes candidates targeting conditions such as depression, anxiety, and other neuropsychiatric disorders.
Company News
Reviva Pharmaceuticals will present research data on brilaroxazine's treatment effects on negative symptoms in schizophrenia patients at the CNS Summit 2025 in Boston, Massachusetts.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are surging after the company released topline results of its pivotal Phase 3 RECOVER trial evaluating brilaroxazine, a serotonin-dopamine signaling modulator in adults with schizophrenia. The trial met its primary endpoint, with brilaroxazine at the 50 mg dose achieving a statisticall...
Penny stocks with bullish analyst ratings. Time to buy or avoid entirely? The post 4 Penny Stocks To Buy According To Analysts Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
